Abstract:Background: Two of the most prevalent causes of severe bacterial meningitis in children, Haemophilus influenzae type B (Hib) and Streptococcus pneumoniae, are preventable by existing vaccines increasingly available in developing countries. Our objective was to estimate the dose-specific effect of Hib and pneumococcal conjugate vaccines (PCV) on childhood meningitis mortality in low-income countries for use in the Lives Saved Tool (LiST). Methods: We systematically searched and reviewed published vaccine efficacy trials and observational studies reporting the effect of Hib or PCV vaccines on organism-specific meningitis, bacterial meningitis and all-cause meningitis incidence and mortality among children less than five years old in low- and middle-income countries. Data collection and quality assessments were performed using standardized guidelines. For outcomes available across multiple studies (≥ 2) and approximating meningitis mortality, we pooled estimates reporting dose-specific effects using random effects meta-analytic methods, then combined these with meningitis etiology data to determine the preventable fraction of childhood meningitis mortality for inclusion in LiST. Results: We identified 18 studies of Hib conjugate vaccines reporting relevant meningitis morbidity and mortality outcomes (2 randomized controlled trials [RCTs], 16 observational studies) but few provided dose-specific effects. A meta-analysis of four case-control studies examined the dose-specific effect of Hib conjugate vaccines on Hib meningitis morbidity (1 dose: RR=0.64, 95% CI 0.38-1.06; 2 doses: RR=0.09, 95% CI 0.03-0.27; 3 doses: RR=0.06, 95% CI 0.02-0.22), consistent with results from single RCTs. Pooled estimates of two RCTs provided evidence for the effect of three doses of PCV on vaccine-serotype meningitis morbidity (RR=0.16, 95% CI 0.02-1.20). We considered these outcomes of severe disease as proxy estimates for meningitis mortality and combined the estimates of protective effects with meningitis etiology data to provide an estimate of the preventable fraction of childhood meningitis mortality with three doses of Hib (38-43%) and pneumococcal conjugate vaccines (28-35%) for use in LiST. Conclusions: Few RCTs or vaccine effectiveness studies evaluated the dose-specific impact of Hib and PCV vaccines on childhood meningitis mortality, necessitating use of proxy measures to estimate population impact in LiST. Our analysis indicates that approximately three-quarters of meningitis deaths are preventable with existing Hib and PCV vaccines.

A Hib Vaccine Battle with Haemophilus Influenzae

Epidemic Trends and Biofilm Formation Mechanisms of Haemophilus Influenzae: Insights into Clinical Implications and Prevention Strategies

Molecular Epidemiology and Evolution of Haemophilus Influenzae

[Progress toward molecular determinants of the pathogenesis of disease due to nontypeable Haemophilus influenzae]

Epidemiological Features and Antibiotic Resistance Patterns of Haemophilus Influenzae Originating from Respiratory Tract and Vaginal Specimens in Pediatric Patients.

Coverage of Haemophilus influenzae Type b Conjugate Vaccine for Children in Mainland China: Systematic Review and Meta-Analysis.

Trends in invasive Haemophilus influenzae serotype b (Hib) disease in England: 2012/13 to 2022/23

Analysis on antibiotic resistance patterns and epidemiological features of 546 Haemophilus influenzae strains isolated from children during 2007-2014 in Children’s Hospital,Zhejiang University School of Medicine

Investigation of Naturally Acquired Antibody to Haemophilus influenzae Type b Polysaccharide in China

The effect of Haemophilus influenzae type B and pneumococcal conjugate vaccines on childhood meningitis mortality: a systematic review

Study on the Resistance of Haemophilus Influenzae from Children with Respiratory Tract Infection

Hemophilus meningitis – Current Aspects of Epidemiology and Prevention: a Descriptive Review

Post-Marketing Surveillance of Adverse Events Following Immunization with Haemophilus Influenzae Type b Conjugate Vaccine - China, 2010-2021

Prevalence of Haemophilus Influenzae Type B Infection in Chinese Children: a Systematic Review and Meta-Analysis

Molecular characteristics and biofilm formation capacity of nontypeable Haemophilus influenza strains isolated from lower respiratory tract in children

Invasive Haemophilus influenzae Infections in Germany After the Introduction of Routine Childhood Immunization, 2001-2016

Epidemiological Analysis and Rapid Detection by One-Step Multiplex PCR Assay of Haemophilus Influenzae in Children with Respiratory Tract Infections in Zhejiang Province, China

Serum Concentrations of Antibodies Against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus Influenzae in Children and Adults of Different Ages

[Clinical Characteristics of 84 Children with Invasive Haemophilus Influenzae Infection from 2014 to 2018].

Disparate kinetics in immune response of two different Haemophilus influenzae type b conjugate vaccines: Immunogenicity and safety observations from a randomized controlled phase IV study in healthy infants and toddlers using a 2+1 schedule

Haemophilus influenzae type b carriage and burden of its related diseases in Chinese children: Systematic review and meta-analysis